A new Wall Street Journal report revealed that Merck is in “advanced talks” to acquire Seattle-area biotech giant Seagen in a deal that could be worth $40 billion or more.… Read More
The Bill & Melinda Gates Foundation will provide up to $120 million to help lower-income countries access a new pill to treat COVID-19, the foundation announced Tuesday. Molnupiravir cuts the… Read More
Researchers at the University of Washington will test a once-a-month pill to prevent HIV in women with a new $122 million grant from the Bill and Melinda Gates Foundation. The… Read More
The founder and former CEO of Seattle health tech startup Navigating Cancer, Gena Cook, is suing one of its investors, pharmaceutical giant Merck’s Global Health Innovation Fund, on claims including… Read More
Two months after Merck acquired Seattle-based biotech Immune Design for $300 million, the president of Merck Research Laboratories, Roger Perlmutter, says the city’s life science community has plenty more to… Read More
Merck, one of the world’s largest drugmakers, agreed to buy Seattle-based biotechnology company Immune Design for $300 million in cash. The deal’s price tag, at $5.85 per share, amounted to… Read More
Immunotherapies are quickly increasing survival rates for some of the deadliest cancers in the world. A new study on immunotherapy Keytruda found that using the treatment, in combination with chemotherapy,… Read More
StayWell, a Pennsylvania-based subsidiary of pharmaceutical giant Merck, announced Monday that it has acquired Portland, Ore., based digital health company Provata Health. The terms of the deal were not disclosed,… Read More
Seattle-based Just Biotherapeutics said Monday it closed a $14 million funding round led by the Bill & Melinda Gates Foundation. A group of former Amgen scientists founded JustĀ in 2014. The… Read More
NanoString Technologies, a Seattle-based company that researches how genetic and immune markers can be used to predict patient response to different cancer therapies, announced today that it will join pharmaceutical… Read More